**Table 3 Mean Time (hours) Above ANC Threshold (TATANC) in Study 1**

<table><tr><th colspan="2"></th><th colspan="1"><b>XOLREMDI (N = 14)</b> </th><th colspan="1"><b>Placebo (N = 17)</b> </th></tr>
<tr><td colspan="2"><b>TATANC</b> (hours) </td><td colspan="1"></td><td colspan="1"></td></tr>
<tr><td colspan="1">Baseline </td><td colspan="1">Mean (SD) </td><td colspan="1">0\.0 (0.0) </td><td colspan="1">3\.6 (5.7) </td></tr>
<tr><td colspan="1" rowspan="6">Overall MMRM results </td><td colspan="1">LS mean (SE) </td><td colspan="1">15\.0 (1.89) </td><td colspan="1">2\.8 (1.52) </td></tr>
<tr><td colspan="1">LS mean 95% CI </td><td colspan="1">(11.2, 18.9) </td><td colspan="1">(0.0, 5.9) </td></tr>
<tr><td colspan="1">Difference from placebo: </td><td colspan="2"></td></tr>
<tr><td colspan="1">LS mean difference (SE) </td><td colspan="1">12\.3 (2.49) </td><td colspan="1">- </td></tr>
<tr><td colspan="1">LS mean difference 95% CI </td><td colspan="1">(7.2, 17.4) </td><td colspan="1">- </td></tr>
<tr><td colspan="1">P-value1  </td><td colspan="1"><0.0001 </td><td colspan="1">- </td></tr>
</table>

Abbreviations: ANC = absolute neutrophil count; CI = confidence interval; LS = least squares; MMRM = mixed-model repeated measures; SD = standard deviation; SE = standard error; TAT = time above threshold of 500 cells/Î¼L. [1] The results are based on an MMRM analysis with time above threshold as a dependent variable; treatment, visit (Weeks 13, 26, 39 and 52), treatment\*visit, Ig use (randomization strata), and baseline time above threshold as covariates; and patient as the repeated random effect.
